SciLifeLab

What SciLifeLab does

SciLifeLab (Science for Life Laboratory) is a Swedish national research infrastructure founded in 2010 as a joint initiative of Karolinska Institutet, KTH Royal Institute of Technology, Stockholm University, and Uppsala University, now represented at most Swedish universities. The organization provides researchers in biomedicine, ecology, and evolution with access to advanced technologies and dedicated staff-scientist support across nine core platforms: Genomics, Proteomics, Metabolomics and Exposomics, Spatial Omics, Cellular and Molecular Imaging, Structural Biology, Chemical Biology and Genome Engineering, Drug Discovery, and Bioinformatics. Three strategic areas—Planetary Biology, Translation to Healthcare (Precision Medicine), and Pandemic Laboratory Preparedness—organize cross-platform programs; the pandemic preparedness line was government-commissioned at 130 MSEK for 2021–2024.

The business model is government-commissioned infrastructure rather than commercial SaaS or product sales. SciLifeLab is funded through Swedish government allocations, founding-university support, and program-specific grants (e.g., 12 MSEK for the SPRINTR precision-medicine cancer platform via the National Board of Health and Welfare). Pricing is not publicly disclosed; users access platforms via their host universities, healthcare institutions (notably Karolinska University Hospital), and approved research collaborations. Notable technical outputs include the SIXP spatial interactomics platform (with Navinci, Uppsala University, CBCS, and Pixl Bio), the ProBio Prostatacancer Assay (cfDNA sequencing for BRCA1/BRCA2 with the Jumble bioinformatic algorithm, now in routine clinical use across the Nordics), and the Clinical Genomics facility (more than 130,000 samples analyzed and 22,000+ whole genomes sequenced during 2021–2024). Distribution is concentrated in Sweden across Stockholm, Uppsala, Solna, Lund, Umeå, Linköping, and Gothenburg, with early Nordic-region extension through the ProBio Assay.

Name

SciLifeLab

Legal name

Science for Life Laboratory (SciLifeLab)

Website

https://scilifelab.se

Company type

Private

Founded year

2010

Operating status

Operating

Headcount range

501–1,000 employees

Short description

SciLifeLab is a Swedish national research infrastructure founded in 2010, providing academic, healthcare, and industry researchers with access to nine advanced molecular bioscience platforms—including genomics, proteomics, spatial omics, and drug discovery—and supporting staff across most Swedish universities.

Ownership category

akta.pro rank

Product category

Life Science Research Infrastructure

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714)

akta.pro primary industry

Biomedical Sciences & Medical Research Institutes (University-Based) (EDAHAGAI)

akta.pro secondary industries

Synthetic Biology & Genetic Circuit Design Platforms (pathway engineering, chassis development) (HLAAAIAD), Biology & Life Science Enrichment (Biotech, Genetics, Anatomy) (EDAMABAF)

Keywords

• Life science infrastructure
• Molecular bioscience research
• Genomics services
• Proteomics services
• Biomedical research platform

Headquarters

HQ city

Solna

HQ country

Sweden

HQ region

Europe

Offices6 records

Markets served

GTM type

B2B

Offering type

Services

Revenue model

1. Research Infrastructure Services: SciLifeLab provides access to advanced research technologies and expertise to researchers in academia, healthcare, and industry. As a government-commissioned national infrastructure, funding comes from government sources, with services provided to users across Sweden's research ecosystem.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

No substantive information about SciLifeLab's core offerings was provided in the source input.

Product overview

SciLifeLab (Science for Life Laboratory) is a state-of-the-art national infrastructure for life science that operates as a platform-plus-core-facilities architecture. The core consists of nine technology platforms: Genomics, Proteomics, Metabolomics and Exposomics, Spatial Omics, Cellular and Molecular Imaging, Structural Biology, Chemical Biology and Genome Engineering, Drug Discovery, and Bioinformatics. These are complemented by strategic capabilities including Planetary Biology, Translation to Healthcare (Precision Medicine), and Pandemic Laboratory Preparedness. The organization offers the Training Portal for educational resources, runs the PULSE postdoctoral training program, and manages flagship research initiatives. Key products include the SIXP Platform for high-throughput spatial interactomics and the ProBio Prostatacancer Assay for metastatic prostate cancer diagnostics. The Clinical Genomics facility provides advanced DNA/RNA sequencing services, and the organization administers the Science & SciLifeLab Prize for Young Scientists. Collaboration across disciplines and sectors involves healthcare, academia, industry, and international communities to enable life science research.

Differentiator

Problem solved

Functional benefit

Brands

• Science & SciLifeLab Prize for Young Scientists: A global prize established in 2013, awarded in partnership with Science magazine/AAAS to recognize scientists at an early stage of their careers.

Quantifiable outcome

• 40% molecular diagnosis rate for rare inherited diseases
• +2 more outcomes

Named customers3 records

Segments3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability4 records

Feature3 records

Partnerships

13 partnerships are on record, tiered core, strategic and minor.

• Karolinska InstitutetcoreStrategic or Co-development PartnerFounding partner of SciLifeLab along with KTH Royal Institute of Technology, Stockholm University, and Uppsala University. Founded in 2010 as a joint effort. Karolinska Institutet hosts Clinical Genomics Stockholm facility and key researchers including Johan Lindberg.
• KTH Royal Institute of TechnologycoreStrategic or Co-development PartnerFounding partner of SciLifeLab. Contributes research expertise and hosts infrastructure facilities as part of the national research collaboration.
• Stockholm UniversitycoreStrategic or Co-development PartnerFounding partner of SciLifeLab. Contributes academic research capabilities and expertise to the national infrastructure collaboration.
• Uppsala UniversitycoreStrategic or Co-development PartnerFounding partner of SciLifeLab. Hosts SciLifeLab Uppsala facilities including Navet BMC. Collaborates on research projects including the Navinci spatial interactomics collaboration.
• NavincistrategicStrategic or Co-development PartnerCross-institutional collaboration to develop the SIXP platform for high-throughput spatial interactomics. Project combines Navinci's multiplex in situ proximity ligation assay technology with cell painting and AI-driven image analysis for drug discovery.
• Chemical Biology Consortium Sweden (CBCS)strategicStrategic or Co-development PartnerCBCS infrastructure at SciLifeLab will implement the established SIXP technology for national access to spatial interactomics capabilities for researchers across Sweden.
• Pixl BiominorStrategic or Co-development PartnerCollaborator in cross-institutional project for high-throughput spatial interactomics platform development.
• Karolinska University HospitalcoreStrategic or Co-development PartnerClinical implementation partner for ProBio Prostatacancer Assay developed by SciLifeLab and Karolinska Institutet researchers. Now offers routine diagnostic testing for metastatic prostate cancer patients.
• Region VästerbottenstrategicStrategic or Co-development PartnerLead organization for SPRINTR study receiving 12 million SEK government funding to develop national research platform in precision medicine for cancer.
• Umeå UniversitystrategicStrategic or Co-development PartnerPartner in SPRINTR study leading development of national research platform in precision medicine for cancer, alongside Region Västerbotten.
• Genomic Medicine SwedenstrategicStrategic or Co-development PartnerReceiving government funding as part of precision health initiatives under same government decision as SPRINTR study.
• Biobank SwedenstrategicStrategic or Co-development PartnerReceiving government funding as part of precision health initiatives under same government decision as SPRINTR study.
• National Board of Health and Welfare (Socialstyrelsen)coreOthersGovernment body providing 12 million SEK funding for SPRINTR study and precision medicine platform development, with additional funding to Genomic Medicine Sweden and Biobank Sweden.

Scale indicators10 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• European Molecular Biology Laboratory (EMBL): EMBL is Europe's flagship intergovernmental life-sciences research infrastructure offering advanced technology platforms (genomics, structural biology, imaging, bioinformatics) to member-state researchers. Highly comparable to SciLifeLab in mission, governance, and core facility portfolio, though operating at a pan-European rather than national scale.
• Broad Institute of MIT and Harvard: Broad is a leading US genomics and chemical biology research institute operating shared technology platforms (genomics, proteomics, imaging, chemistry) serving academic and clinical researchers. Comparable platform-plus-research model to SciLifeLab, at larger scale and with deeper commercial spin-out activity.
• The Francis Crick Institute: The Crick is a UK biomedical discovery institute with interdisciplinary research groups and shared core technology facilities. Comparable to SciLifeLab's model of clustering infrastructure around a multi-institutional research community focused on molecular biosciences.
• Nordic EMBL Partnership for Molecular Medicine: The Nordic EMBL Partnership is a network of Nordic molecular medicine research nodes (including nodes in Sweden, Denmark, Norway, Finland) with overlapping missions to SciLifeLab. Directly comparable as a regional, multi-node, publicly funded life science infrastructure operating in the same geographic ecosystem.
• Genomics England: Genomics England is a UK government-owned company running the 100,000 Genomes Project and providing clinical whole-genome sequencing infrastructure for the NHS. Directly comparable to SciLifeLab's Clinical Genomics and rare disease sequencing initiatives from a translational genomics perspective.
• Wellcome Sanger Institute: Sanger is a UK-based genomics and bioinformatics research institute operating large-scale DNA sequencing, cancer genomics, and infectious disease surveillance capabilities. Directly comparable to SciLifeLab's Clinical Genomics Stockholm in scale, mission, and translational genomics focus.

Broad incumbents

• Illumina: Illumina is the dominant commercial DNA sequencing platform provider and runs its own accelerator and genomics network programs. Indirect peer in that SciLifeLab's Clinical Genomics operations depend on Illumina technology while also competing for translational genomics mindshare.
• 10x Genomics: 10x Genomics is a US-based commercial provider of single-cell, spatial omics, and genomics platforms used widely by research infrastructure operators. Overlaps with SciLifeLab's Genomics, Spatial Omics, and Cellular Imaging platforms from a technology-provider standpoint, though as a vendor rather than a peer institute.
• Max Planck Institutes (Biomedical Section): The Max Planck Society operates a broad network of biomedical research institutes across Germany with shared infrastructure and core facilities. Overlaps with SciLifeLab in providing large-scale, publicly funded life science infrastructure, though distributed across many specialized institutes rather than centralized.

Regional players

• Babraham Institute: Babraham is a UK life sciences research institute focused on epigenetics, signaling, and immunology with shared research infrastructure. Smaller-scale peer in the same European ecosystem, comparable in its mix of academic research groups and core facility access.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/scilifelab
• GitHubgithub.com/SciLifeLab
• LinkedInlinkedin.com/company/scilifelab
• Facebookfacebook.com/scilifelab

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SciLifeLab